# ClinicalTrials.gov record NCT01166958

> PeptideScanner retained ClinicalTrials.gov record NCT01166958 at 2026-07-30T21:54:46.558Z. Its registry update date was 2014-09-22, and PeptideScanner's reviewed identity mapping was teriparatide.

- Evidence object: `story:clinicaltrials-gov-nct01166958-teriparatide:v1`
- Evidence domain: Clinical trials
- Date in source: 2014-09-22
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct01166958-teriparatide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct01166958-teriparatide-v1.json
- Content SHA-256: `5d812b804d3e20a622852364a5b4d809234370a095ec716e105d8e793976c172`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT01166958 ([`ctg-observation-nct01166958-2014-09-22-7e8f447f7d5e`](#source-ctg-observation-nct01166958-2014-09-22-7e8f447f7d5e))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT01166958 at 2026-07-30T21:54:46.558Z. Its registry update date was 2014-09-22, and PeptideScanner's reviewed identity mapping was teriparatide. ([`ctg-observation-nct01166958-2014-09-22-7e8f447f7d5e`](#source-ctg-observation-nct01166958-2014-09-22-7e8f447f7d5e))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT01166958 at 2026-07-30T21:54:46.558Z. Its registry update date was 2014-09-22, and PeptideScanner's reviewed identity mapping was teriparatide. ([`ctg-observation-nct01166958-2014-09-22-7e8f447f7d5e`](#source-ctg-observation-nct01166958-2014-09-22-7e8f447f7d5e))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct01166958-2014-09-22-7e8f447f7d5e`](#source-ctg-observation-nct01166958-2014-09-22-7e8f447f7d5e))

## Sources

<a id="source-ctg-observation-nct01166958-2014-09-22-7e8f447f7d5e"></a>
- **ClinicalTrials.gov record NCT01166958 · retained source version 2014-09-22:7e8f447f7d5ef8579722f4e66e720893d2029d2830f4f13fa7023aed043c20dd** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT01166958) (`ctg-observation-nct01166958-2014-09-22-7e8f447f7d5e`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT01166958." Version 1, published 2026-08-09. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct01166958-teriparatide-v1.json SHA-256: 5d812b804d3e20a622852364a5b4d809234370a095ec716e105d8e793976c172.